Efficacy and Safety of Brolucizumab for Diabetic Macular Edema

Дата публикации: 01-12-2023 00:00:00

This randomized clinical trial evaluates the efficacy and safety of brolucizumab vs aflibercept dosed every 4 weeks in participants with diabetic macular edema.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Sterile Intraocular Inflammation Associated With Faricimab	0	9.17	01-11-2024
2	Metformin Use and Age-Related Macular Degeneration in Patients With Diabetes	0	9.02	01-07-2026
3	Detecting Glaucoma in Myopic Eyes With OCT	0	7	02-07-2026
4	Photo Finish First Year For Avastin and Lucentis	0	12.81	24-07-2026
5	Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia	0	13.66	01-06-2024
6	Economic Burden of Late-Stage Age-Related Macular Degeneration in Bulgaria, Germany, and the US	0	15.59	01-12-2024
7	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
8	Diabetic Retinopathy and Quality of Life	0	8.72	01-03-2024
9	Teriflunomide and Time to Clinical Multiple Sclerosis in Radiologically Isolated Syndrome	0	6.92	01-10-2023
10	Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy	0	7.7	01-08-2024

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.97. Источник: jamanetwork.com.